Tozorakimab (formerly MEDI 3506) is a monoclonal antibody that targets interleukin-33 (IL-33) and is currently being evaluated in clinical trials as a treatment for chronic obstructive pulmonary disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.